Patricia Spilman

5PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 07, 2024
Recurrent pancreatic cancer treated with N-803 and PD-L1 t-haNK followed by an EGFR-targeted nanocell drug conjugate.

Katayoun Moini, Tara Seery, Chaitali Nangia

|Jan 16, 2024
Quality of Life in the Phase 2/3 Trial of N-803 Plus Bacillus Calmette-Guérin in Bacillus Calmette-Guérin‒Unresponsive Nonmuscle-Invasive Bladder Cancer.

Karim Chamie, Sam S Chang, Eugene V Kramolowsky

|Apr 04, 2023
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial.

Peter A Fasching, Christopher Szeto, Carsten Denkert

|Mar 16, 2022
Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer.

Kimberly A Burton, Elisabeth Mahen, Eric Quentin Konnick

|Jun 26, 2021
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy.

Hannah Reimann, Andrew Nguyen, J Zachary Sanborn

Pageof 1

Frequent Collaborators

3 joint publications

Patrick Soon-Shiong

2 joint publications

Shahrooz Rabizadeh

2 joint publications

Stephen Charles Benz

1 joint publications

James L Gulley